Invention Grant
- Patent Title: Heterocyclic compound
-
Application No.: US14781963Application Date: 2014-04-03
-
Publication No.: US09598398B2Publication Date: 2017-03-21
- Inventor: Tatsuki Koike , Masato Yoshikawa , Haruhi Ando , William John Farnaby , Shuhei Ikeda , Yuichi Kajita , Toshiya Nishi
- Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Applicant Address: JP Osaka
- Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee Address: JP Osaka
- Agency: Wenderoth, Lind & Ponack, L.L.P.
- Priority: JP2013-079023 20130404
- International Application: PCT/JP2014/059892 WO 20140403
- International Announcement: WO2014/163161 WO 20141009
- Main IPC: C07D401/14
- IPC: C07D401/14 ; C07D403/14 ; A61K31/497 ; A61K31/4545 ; A61K31/444 ; C07D401/10 ; C07D403/12 ; C07D405/14 ; C07D413/14 ; C07D401/12 ; C07D239/26 ; C07D417/14 ; C07D213/34 ; C07D213/56 ; C07D213/42
Abstract:
The present invention relates to a compound represented by the formula (I), which is useful as an agent for the prophylaxis or treatment of epilepsy, neurodegenerative disease and the like. In the formula (I), each symbol is as defined in the specification.
Public/Granted literature
- US20160024049A1 HETEROCYCLIC COMPOUND Public/Granted day:2016-01-28
Information query
